Friday, December 09, 2016 11:37:02 AM
http://www.australian-companies.tsetso.info/company.php?oncosec-medical-australia-pty-ltd-acn-abn-number-615228941
As you noted Jeff...
https://www.aimatmelanoma.org/about-melanoma/melanoma-stats-facts-and-figures/
Not only will the Australian subsidiary speed up enrollment for the registration trial, but it will open OncoSec to the biggest melanoma market in the world post approval. We could be looking at late 2019 if the data is great. Not a long time considering the average time a drug takes from start to market is 10-15 years.
https://www.ncbi.nlm.nih.gov/books/NBK22930/
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM